Loading...
|
Please use this identifier to cite or link to this item:
http://140.112.114.62/handle/246246/171570
|
| Title: | Lanreotide Treatment in a Patient with Interferon-Associated Graves Ophthalmopathy |
| Authors: | 蘇登煌;張英俊;廖述朗;張天鈞
SU, DENG-HUANG;CHANG, YING-CHUN;LIAO, SHU-LANG;CHANG, TIEN-CHUN |
| Contributors: | 眼科部 |
| Date: | 2005 |
| Issue Date: | 2009-10-21T11:04:19Z
|
| Abstract: | Background We report a case of Graves ophthalmopathy (GO) developed after the administration of interferon- for chronic hepatitis C.Methods The GO was treated with lanreotide.Results A 47-year-old female patient presented with euthyroid GO with spontaneous retrobulbar pain, eyelid edema, conjunctival injection and eyelid retraction of the right eye and conjunctival injection of the left eye 6 months after administration of interferon- for chronic hepatitis C. Orbital computed tomography revealed no involvement of extraorbital muscles and no increase in retrobulbar adipose tissue. Only soft tissue was involved. These symptoms subsided after 12 weeks of lanreotide treatment, except right eyelid retraction, which, however, disappeared later during follow-up.Conclusion The use of interferon- may be complicated by GO and lanreotide might be considered for GO if patients cannot accept steroid therapy . |
| Relation: | GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY v.243 n.3 pp.269-272 |
| Appears in Collections: | [附設醫院眼科部] 期刊論文
|
Files in This Item:
There are no files associated with this item.
|
All items in NTUR are protected by copyright, with all rights reserved.
|
